Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis

NCT01654731 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

PBC

Interventions

DRUG: Bezafibrate
DRUG: placebo

Sponsor

Assistance Publique - Hôpitaux de Paris